HealthDay - WEDNESDAY, May 14 (HealthDay News) -- Tonsil and tongue cancers
linked to human papillomavirus (HPV) are most responsive to current
chemotherapy and radiation treatments, while those that express high
levels of a growth factor called EGFR are the least responsive and most
deadly, a new study concludes.